JP2014098037A5 - - Google Patents

Download PDF

Info

Publication number
JP2014098037A5
JP2014098037A5 JP2014037949A JP2014037949A JP2014098037A5 JP 2014098037 A5 JP2014098037 A5 JP 2014098037A5 JP 2014037949 A JP2014037949 A JP 2014037949A JP 2014037949 A JP2014037949 A JP 2014037949A JP 2014098037 A5 JP2014098037 A5 JP 2014098037A5
Authority
JP
Japan
Prior art keywords
formulation
infection
tissue
sodium
dichlorotaurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2014037949A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014098037A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014098037A publication Critical patent/JP2014098037A/ja
Publication of JP2014098037A5 publication Critical patent/JP2014098037A5/ja
Withdrawn legal-status Critical Current

Links

JP2014037949A 2007-05-01 2014-02-28 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸 Withdrawn JP2014098037A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91527107P 2007-05-01 2007-05-01
US60/915,271 2007-05-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010506585A Division JP2010526084A (ja) 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸

Publications (2)

Publication Number Publication Date
JP2014098037A JP2014098037A (ja) 2014-05-29
JP2014098037A5 true JP2014098037A5 (enExample) 2014-08-07

Family

ID=39616420

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010506585A Withdrawn JP2010526084A (ja) 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸
JP2014037949A Withdrawn JP2014098037A (ja) 2007-05-01 2014-02-28 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010506585A Withdrawn JP2010526084A (ja) 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物を含む脂肪族系酸

Country Status (17)

Country Link
US (2) US20080275126A1 (enExample)
EP (1) EP2139520B1 (enExample)
JP (2) JP2010526084A (enExample)
KR (1) KR20100017156A (enExample)
CN (1) CN101678105A (enExample)
AR (1) AR066371A1 (enExample)
AU (1) AU2008245460B2 (enExample)
BR (1) BRPI0811073A2 (enExample)
CA (1) CA2684101A1 (enExample)
CL (1) CL2008001283A1 (enExample)
ES (1) ES2432408T3 (enExample)
MX (1) MX2009011817A (enExample)
RU (1) RU2009144291A (enExample)
TW (1) TW200902092A (enExample)
UY (1) UY31057A1 (enExample)
WO (1) WO2008134692A1 (enExample)
ZA (1) ZA200907052B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2265267B1 (en) * 2008-04-10 2016-09-21 Waldemar Gottardi Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
EP2271331A1 (en) * 2008-04-15 2011-01-12 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027965B2 (ja) * 1980-02-23 1985-07-02 東洋コンタクトレンズ株式会社 コンタクトレンズに付着した汚れの除去方法
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
AU3070395A (en) * 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6387427B1 (en) * 2000-09-28 2002-05-14 Nestec S.A. Method of preservation of a food product
JP4502641B2 (ja) * 2002-01-24 2010-07-14 ティルタン ファーマ リミテッド 抗癌組み合わせおよびその使用方法
CN1902158B (zh) * 2003-08-18 2011-04-06 诺华科尔制药公司 N,n-二卤代氨基酸及其衍生物
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法
US20070244449A1 (en) * 2005-10-06 2007-10-18 Novacal Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including Urinary Tract Infections (UTI) using N-halogenated amino acids

Similar Documents

Publication Publication Date Title
PL3672954T3 (pl) Związki, ich sole i ich zastosowanie w leczeniu chorób
IL272314A (en) Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
HUE036220T2 (hu) Kinazolin származékok vírusfertõzések és további betegségek kezelésére
PL3556377T3 (pl) Dalargin do stosowania w leczeniu ostrych infekcji wirusowych dróg oddechowych
PL3405215T3 (pl) Sposoby leczenia choroby danona i innych zaburzeń autofagii
JP2011516477A5 (enExample)
MX2017012272A (es) Solucion para inhalacion de tiotropio para nebulizacion.
IL283469A (en) Inhalable preparations for use in the treatment of lung diseases
HUE044731T2 (hu) Formulációk a száj, torok és respiratorikus traktus rendellenességeinek kezelésére
EP3927428A4 (en) METHODS OF TREATMENT OF RESPIRATORY DISEASES
PL3204375T3 (pl) Spiroindoliny do leczenia i zapobiegania zakażeniu syncytialnym wirusem nabłonka oddechowego (RSV)
NZ753749A (en) Treatment of respiratory tract diseases and infections with glutathione compositions
JP2014098037A5 (enExample)
EP4132547A4 (en) ALKALINE RESPIRATORY EPITHELIUM THERAPY TO TREAT VIRAL RESPIRATORY INFECTION
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
JP2012508693A5 (enExample)
JP2015508052A5 (enExample)
MX381932B (es) Composicion intranasal que comprende betahistina.
EA201592299A1 (ru) Полуживая вирусная вакцина против респираторно-синцитиального вируса
WO2016072854A3 (en) Pantothenamide analogues
NZ740722A (en) Oral suspension for treating eosinophilic esophagitis
JP2018058789A5 (enExample)
EP3094330A4 (en) Treatment of crohn's disease using low doses of laquinimod
JP2019074725A5 (enExample)
HUE054772T2 (hu) Pirimidinszármazékok és alkalmazásuk respiratorikus szinciciális vírusfertõzés kezelésében vagy megelõzésében